US Patent Issued to International AIDS Vaccine Initiative, The Scripps Research Institute, Theraclone Sciences on Sept. 9 for "Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies" (American, Swiss Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,243, issued on Sept. 9, was assigned to International AIDS Vaccine Initiative Inc. (New York), The Scripps Research Institute (La Jolla, Calif.) and Theraclone Sciences Inc. (Seattle).

"Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies" was invented by Po-Ying Chan-Hui (Bellevue, Wash.), Katherine Doores (San Diego), Michael Huber (Zurich), Stephen Kaminsky (Bronx, N.Y.), Steven Frey (Redmond, Wash.), Ole Olsen (Everett, Wash.), Jennifer Mitcham (Redmond, Wash.), Matthew Moyle (Redmond, Wash.), Sanjay K. Phogat (Frederick, Md.), Dennis R. Burton (La Jolla, Calif.), Laura Majorie Walk...